To boost immunoglobulins targeting flagellin, repeated flagellin intraperitoneal injections in mice elicited a mucosal flagellin-specific IgA antibody response that can alter the intestinal bacterial profile, reducing flagellin expression to prevent microbial encroachment, lower inflammation, and protect against diet-induced obesity (47). Here, CD79A is linked to obesity disorder.